The primary outcome measure being assessed was the change in HbA1c from baseline to the end of treatment at week 32, while seconday outcome measures were related to endpoints of continuous glucose monitoring included time in range and time aboe range [2]
Helene H Hansen Duus and Katrine Kirkeby were responsible for the statistical analyses
Essential Guideline #8: Adjusting Dosage for Special Populations Vitamin B12 treatment isnt the same for everyone
The key to success lies in starting with established protocols, monitoring your response carefully, and making informed adjustments based on your unique biology and goals
Richter RP, Ashtekar AR, Zheng L, Pretorius D, Kaushlendra T, Sanderson RD, Gaggar A, Richter JR
I cant say enough good things